NCT04453605View on ClinicalTrials.gov

Phenotyping Individuals With Neo-diagnosed Type 2 Diabetes at Risk for All-cause Mortality

CompletedOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

January 1, 2008

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2018

Conditions
Type 2 DiabetesVascular DiseasesCardiac Disease
Interventions
OTHER

standard treatments

patients were treated according to the good clinical practice recommended by the international guidelines, and followed a six-month or an yearly calendar of follow-up visits

Trial Locations (1)

56125

University of Pisa, Pisa

All Listed Sponsors
lead

University of Pisa

OTHER

NCT04453605 - Phenotyping Individuals With Neo-diagnosed Type 2 Diabetes at Risk for All-cause Mortality | Biotech Hunter | Biotech Hunter